The cytokine interleukin-1b (IL-1b) is cytotoxic to rat [1] and human pancreatic beta cells in synergy with tumour necrosis factor-a (TNFa) and interferon-g (IFNg) [2, 3] . Inactivating IL-1b by treatment with soluble IL-1b receptors protects against diabetes development in non-obese diabetic (NOD) mice [4] . The three cytokines could therefore be important effector molecules in the pathogenesis of insulin-dependent diabetes mellitus by inducing beta-cell apoptosis or necrosis or both [5] . Cytokines have been proposed to induce rat beta-cell damage through expression of cytokine inducible nitric oxide synthase (iNOS) leading to nitric oxide (NO) generation [6] , whereas cytokine-induced apoptosis in human islets is probably independent of NO generation [7] . Further, NO generation might not be sufficient to medi- 
ate the inhibitory and toxic effects of cytokines on rat pancreatic beta cells.
Mitogen-activated and stress-activated protein kinases (MAP/SAPKs) have been suggested to signal both NO-dependent as well as NO-independent deleterious pathways in rat islets of Langerhans [8] . The MAP/SAPKs include extracellular-signal-regulated kinase (ERK) 1 and 2, c-Jun NH 2 -terminal kinases (JNKs) and p38 s [9] . These kinases determine cell proliferation, differentiation or apoptosis in response to extracellular signals [9] and are activated by phosphorylation on threonine and tyrosine residues by upstream kinases [9] . The MAP/SAPKs are prolinedirected threonin/serine kinases phosphorylating among other substrates Elk-1, activating transcription factor-2 (ATF-2) and c-jun [9±11], the latter together with fos or ATF subunits leading to formation of the transcription factor activating protein-1 (AP-1) [12] . The substrate specificity of MAPK could be mediated by scaffolding proteins such as JNK interacting protein 1 (JIP-1) and MEK partner 1 (MP1), targeting JNK and ERK to certain substrates, respectively [13±15] . Cellular expression of the scaffolding proteins could thus participate in directing and controlling activation of MAPK pathways.
Because TNFa and IFNg potentiate IL-1b-induced inhibition and toxicity in beta cells [3, 7, 16, 17] , the aim of this study was to investigate whether they signal through MAPK and influence IL-1b-induced MAPK activity in rat pancreatic islets.
We report that IL-1b (concentration-dependently) and to a lesser degree TNFa activate MAPKs and that combinations of IL-1b, TNFa and IFNg synergistically increase MAPK and especially p38 activity in isolated rat islets of Langerhans.
Materials and methods
Reagents. All reagents were from Sigma (St. Louis, Mo., USA) unless otherwise specified. Recombinant human IL-1b (400 units/ng) was from Novo Nordisk (Bagsvñrd, Denmark). Recombinant human TNFa (2 10 7 U/mg) and recombinant rat IFNg (5 10 6 U/mg) were from Genzyme (West Malling, Kent, England). Reagents for SDS-polyacrylamide gel electrophoresis (SDS-PAGE) were all from Bio-Rad (Richmond, Calif., USA). We obtained [g- 32 P]ATP (110 TBq/mmol) from Amersham Pharmacia BioTech (Amersham, UK), glutathione S-transferase (GST)-Elk-1 was a gift from K. Seedorf (Hagedorn Research Institute, Denmark), GST-ATF-2 (1±109) was a gift from R. J. Davis (Howard Hughes Medical Institute, University of Massachusetts Medical School, Worcester, Mass., USA) and recombinant murine 25 000 M r heat-shock protein (HSP25) was from Stressgen (Victoria, Canada).
Islet isolation and preculture. Islets of Langerhans from 5-to 7-day-old Wistar Furth rats (Charles River, Sulzfeldt, Germany) were isolated by handpicking after collagenase A (Boehringer-Mannheim, Mannheim, Germany) digestion of the pancreata [18] . Islets were precultured in 5-ml dishes (Nunc, Roskilde, Denmark) for 7 days at 37 C in atmospheric humidified air in complete medium (RPMI 1640 with 11 mmol/l glucose supplemented with 100 000 U/l penicillin, 100 mg/l streptomycin, 20 mmol/l HEPES buffer, 2 mmol/l l-glutamine, 0.038 % NaHCO 3 (all from Life Technologies, Paisley, Scotland)), and 10 % FCS (Life Technologies). Principles of animal care (NIH publication no. 85±23, revised 1985) were followed and animals were handled according to permission obtained from the Committee for Inspection of Animal Experiments under the Danish Ministry of Justice.
Islet culture. We picked 150 islets at random and cultured them in 300 ml complete medium + 0.5 % human serum in four-well plates (Nunc) before adding the cytokines. Islets were exposed to cytokines for 20 min before lysis [8] .
We investigated the effect of pre-incubation on MAP kinase activity before addition of cytokines to find the effect of stress caused by handling the islets during the washing procedure. Experiments were performed with increasing pre-incubation times from 0 to 24 h followed by 20 min exposure to 0 or 60 U/ml IL-1b with no intercurrent handling.
Lysis of islets.
After stimulation islets were transferred to 1.5 ml Eppendorf vials and centrifuged for 2.5 min at 5000 rpm at 4 C. The medium was removed and the islets were lysed in 25 ml lysis buffer (20 mmol/l TRIS pH 7.0, 0.27 mol/l sucrose, 1 mmol/l EDTA, 1 mmol/l EGTA, 1 mmol/l Na 3 VO 4 , 50 mmol/l NaF, 1 % Triton X-100, 5 mmol/l sodium pyrophosphate, 10 mmol/l b-glycerophosphate, 1 mmol/l dithiothreitol (DTT), 1 mmol/l benzamidine and 4 mg/ml leupeptin) for 30±45 min on ice. The detergent-insoluble material was pelleted by centrifugation at 15 000 rpm for 5 min at 4 C. The supernatants containing the whole-islet lysate were stored at ±80 C until use.
Protein concentration in lysates. Using the dye reagent concentrate, Bio-Rad protein assay was done according to the manufacturers instructions.
Whole-cell lysate kinase assay. Whole-cell lysate kinase assay was done as described previously [8] . In brief, 3±5 ml whole-islet lysate (volume of whole islet lysate adjusted to contain same amount of protein) was added to 17 ml reaction buffer (2 mg GST-Elk-1, 2 mg GST-ATF-2, 1 mg HSP25 (the rodent homologue of human HSP27), 25 mmol/l TRIS pH 7.5, 0.1 mmol/ l EGTA, 0.1 mmol/l Na 3 VO 4 , 1 mmol/l cAMP-dependent protein kinase inhibitor peptide and 10 mmol/l Mg-acetate) and 3 ml ATP mixture (1 mmol/l ATP and 0.1 MBq [g-32 P]ATP). The phosphotransferase reactions were carried out at 30 C for 30 min. Reactions were terminated by addition of 25 ml cold SDS sample buffer (125 mmol/l TRIS pH 6.8, 4 % SDS, 0.1 mol/l DTT, 10 % glycerol and 0.02 % bromphenol blue) and boiling for 5 min. We did SDS-PAGE using 4 % stacking gels and 12 % separation gels. After electrophoresis, the upper part of the separation gels were washed in a mixture of 10 % acetic acid and 40 % methanol. The gels were dried, and phosphorylated proteins were visualized by autoradiography using PhosphoImager (Molecular Dynamics, Sunnyvale, Calif., USA) and quantified using ImageQuant software version 3.3 (Molecular Dynamics).
Immunoprecipitation and immunocomplex kinase assay. The immunoprecipitation and immunocomplex kinase assays were done as described previously [8] with minor modifications and using GST-ATF-2 and HSP25 as substrates for ERK1/2 and MAPKAP-K2, respectively. In brief, lysate containing 400 mg protein diluted to a final volume of 1.0 ml in washing buffer (lysis buffer containing 0.1 % Triton X-100) was immunopre-cipitated by incubation for 2 h at 4 C with 2 ml anti-ERK1/2 (New England Biolabs, Hitchin Hertfordshire, UK) or 2 mg anti-MAPKAP-K2 antibodies (Upstate Biotechnology, Lake Placid, N. Y., USA) followed by 2 h of incubation at 4 C with 30 ml Sepharose-protein A beads (Pharmacia Biotech, Uppsala, Sweden). The beads were washed four times in washing buffer and three times in kinase buffer (20 mmol/l HEPES at pH 7.5, 20 mmol/l b-glycerophosphate, 10 mmol/l MgCl 2 , 1 mmol/l DTT and 50 mmol/l Na 3 VO 4 ). Kinase reactions were carried out for 30 min at 30 C in 35 ml kinase buffer containing 0.4 MBq [g- 32 P]ATP and 15 mg GST-ATF-2 (ERK1/2) or 5 mg HSP25 (MAPKAP-K2). Reactions were terminated by addition of 35 ml SDS sample buffer and boiling for 5 min. The samples were then analysed for kinase activity as described above.
Statistical analysis. Results are presented as means SEM. Wilcoxon's matched-pair test was used as a non-parametric statistical test and p less than 0.05 was chosen as the level of significance.
Results
IL-1b and TNFa, but not IFNg significantly increase MAPK activity. To investigate the effect of increasing concentrations of IL-1b, TNFa or IFNg on the activity of p38 and ERK1/2 in isolated rat islets of Langerhans the phosphorylation of Elk-1, ATF-2 and HSP25 was measured by kinase assay of whole-islet lysates from concentration-response experiments with each of the three cytokines.
We found IL-1b caused a concentration-dependent increase in the phosphorylation of HSP25, ATF-2 and Elk-1 at and above 4, 20 and 60 U/ml of IL-1b, respectively (p < 0.05, Fig. 1 ). The peak phosphorylation of Elk-1, ATF-2 and HSP25 was approximately 2-fold, 3-fold and 4.5-fold above baseline activity, respectively. The phosphorylation of the three substrates was not further increased above 60 U/ml IL-1b (data not shown).
The TNFa cytokine increased the phosphorylation of ATF-2 and HSP25 1.3-fold and 1.7-fold of the baseline activity at 250 and 1000 U/ml, respectively (p < 0.05, Fig. 2) , and IFNg reduced the phosphorylation of Elk-1 and ATF-2 at 2.5 and 10 U/ml, respectively (p < 0.05, Fig. 3 ). Higher concentrations of IFNg (1000 U/ml) had no statistically significant effect on the substrate phosphorylation (data not shown).
High constitutive phosphorylation of especially ATF-2 and HSP25 was observed in these experi- ments. We therefore investigated the effect of preincubation of the islets for 0±24 h before addition of IL-1b on the basal phosphotransferase activity. Preincubation had no statistically significant effect on baseline phosphorylation of Elk-1 (Fig. 4) but the IL-1b-induced response significantly increased after 3 h of pre-incubation and tended to decline when using preincubation periods longer than 6 h. The baseline phosphorylations of ATF-2 and HSP25 were significantly reduced when using a pre-incubation period (3 to 12 h and 1 to 3 h, respectively) before exposure to cytokines (Fig. 4) . The baseline phosphorylations of both substrates increased when using pre-incubation periods longer than 12 h. The relative phosphorylation of the three substrates (cytokine-induced phosphorylation divided by baseline phosphorylation of the substrate) was highest when using 3 h of pre-incubation before exposure to cytokines and this optimum was used in the following experiments.
We next compared the relative phosphorylations of Elk-1, ATF-2 and HSP25 induced by IL-1b, TNFa or IFNg in the same experiment after 3 h of pre-incubation (Fig. 5) . The phosphorylation of the substrates Elk-1, ATF-2 and HSP25, after exposure to 60 U/ml IL-1b, increased 3.3-fold, 7-fold and 10.1-fold above the baseline level, respectively (p < 0.025). The phosphorylation of HSP25, ATF-2 and Elk-1 was increased 1.3-to 1.4-fold over baseline by TNFa (p < 0.05 for ATF-2). Exposure to 10 U/ml IFNg tended to reduce the phosphorylation of the Elk-1 and ATF-2 in accordance with data in Fig. 3 (p < 0.025 for ATF-2).
To investigate the kinase specificity we immunoprecipitated ERK1/2 and MAPKAP-K2 from lysates after exposure to IL-1b, TNFa and IFNg for 20 min (Fig. 6 ) because previous studies showed that ERK 1/2 and p38, but not JNK, phosphorylated Elk-1, ATF-2 and HSP25 in IL-1b exposed rat islets [8] . Due to the large amount of tissue needed for immunoprecipitation only one experiment was done to verify the results from the whole-cell lysate kinase assays.
The activity of ERK1/2 and p38 increased considerably after exposure to IL-1b (Fig. 6 ) in accordance with the kinase activity measured by whole-cell lysate kinase assay (Fig. 5 ).
Synergistic effect of combinations of cytokines on MAPK activity. To investigate the effect of combinations of cytokines on the activity of the MAPKs in islets of Langerhans, submaximum concentrations of each cytokine chosen from the concentration-response experiments in Figures 1±3 were used alone or in combinations (Fig. 7) .
We found Elk-1 phosphorylation was increased when exposed to 20 U/ml IL-1b or 250 U/ml TNFa (p < 0.05 and 0.02, respectively vs control and p < 0.02 vs the lower concentration of the same cytokine, Fig. 7 ). The Elk-1 phosphorylation was decreased (p < 0.05) when incubated with 2.5 U/ml IFNg. The ATF-2 and HSP25 phosphorylations were increased when incubated with 4 or 20 U/ml IL-1b or 250 U/ml TNFa (p < 0.05, Fig. 7) .
Addition of low concentrations of TNFa had no effect on the action of the low concentration of IL1b (Fig. 7) . Low concentrations of IFNg decreased the effect of low concentrations of IL-1b on the phosphorylation of HSP25 (p < 0.05, Fig. 7 ). Incubation with low concentrations of all three cytokines decreased the phosphorylation of ATF-2 and HSP25 compared with the same concentrations of IL-1b alone or IL-1b combined with TNFa (p < 0.05).
Low concentrations of IFNg synergistically increased the effects of high concentrations of IL-1b combined with low concentrations of TNFa on the phosphorylation of all three substrates (p < 0.05, Fig. 7) .
The phosphorylation of HSP25 induced by the higher concentrations of TNFa was further increased in an additive manner in the presence of low concentrations of IL-1b (p < 0.05, Fig. 7 ).
We found 2.5 U/ml IFNg reduced IL-1b-induced phosphorylation of all three substrates to the same level of phosphorylation observed with 2.5 U/ml IFNg alone, in that substrate phosphorylation of 2.5 U/ml IFNg was not statistically significantly different from that seen at 2.5 U/ml IFNg + 4 U/ml IL-1b (Fig. 7) .
Discussion
Our results show that IL-1b alone and TNFa alone significantly increased ERK1/2 and p38 activity in rat islets of Langerhans whereas IFNg alone decreased the activity of ERK1/2. Further, in analogy to the potentiating effect of TNFa and IFNg on IL-1b-induced NO synthesis, inhibition of insulin release and toxicity to islet beta cells, the three cytokines synergised in increasing islet MAPK activity within the same or lower concentration range which has been found to synergise with regard to other variables [2, 3, 7] .
We found that TNFa-induced MAPK activity resulted in maximum substrate phosphorylation which was lower than the maximum phosphorylation induced after exposure to IL-1b. The mechanisms of engaging MAPK differ between the IL-1b and TNFa signalling transduction pathways. Binding of IL-1b to the IL-1b receptor type I (IL-1RI) leads to assembly of the IL-1b receptor complex, which include IL-1 receptor-associated protein (IL-1RAcP), MyD88, IL-1b receptor-associated kinase 1 and 2 (IRAK 1/2) [19] and TRAF 6 [20, 21] whereas TNFa binding to TNF receptor type 1 (TNFR1) leads to trimerisation of the TNFR1 and recruitment of TNFR1-associated death domain protein (TRADD) to the death domain of the receptors [22±24]. The TRADD is known to interact with the Fas-associated death domain protein (FADD), TNF receptor-associated factor 2 (TRAF2) and receptor interacting protein (RIP) [25] . Both TRAF 2 and TRAF 6 have been associated with nuclear factor kB (NF-kB) inducing kinase (NIK) induced activation of NFkB [26] . The NIK shares sequence similarity with several MAP kinase kinases and has therefore been suggested to be involved in activation of MAPKs in response to both IL-1b and TNFa [26] . Differences between TRAF 2 and 6 activation of NIK could explain the lower MAPK activity in response to TNFa compared with IL-1b either due to different time-response optima or to differences in the amount of receptor complexes. Combined TRAF 2 and 6 activation of NIK could also explain the additive effect of IL-1b on TNFa-induced MAPK activity.
Interferon gamma alone or when combined in high concentrations with other cytokines reduced the phosphorylation of the ERK substrates. Interferon gamma signalling involves association of homodimeric IFNg with two type I integral membrane proteins . The STAT1-homodimers translocate to the nucleus where they bind to specific gamma-activated sequence (GAS) elements of IFNg-inducible genes. The activity of the STAT proteins can be controlled by phosphorylation of a serine phosphorylation site, which is a possible site of ERK or p38 phosphorylation or both [27, 30] . The increased amount of STAT-dimers after stimulation with IFNg could recruit and associate with activated ERK and p38 and thereby inhibit the phosphoryla- Fig. 6 . Lysates were prepared from islets that had been pre-incubated for 3 h followed by exposure to 60 U/ml IL-1b, 1000 U/ml TNFa or 10 U/ml IFNg for 20 min. ERK 1/2 (upper panel) and MAPKAP-K2 (lower panel) were immunoprecipitated from the lysates and their activities were measured in immunocomplex kinase assay with ATF-2 and HSP25 as substrates (n = 1). After SDS-PAGE phosphorylated proteins were visualised by autoradiography. Optical density quantified using ImageQuant is indicated below the autoradiograms The net effect of serine phosphorylation of STAT proteins has been reported to both potentiate and inhibit tyrosine phosphorylation and transcriptional activity. Thus the net effect could depend on the type of extracellular stimulus, the cell type and the activation state of the cell in question [31±38] .
The synergistic effect of low concentrations of IFNg on MAPK activity induced by IL-1b and TNFa could be mediated by JAK2 (and possibly also by JAK1) activation of MAPKs through activation of Raf1 [27, 39] .
Cytokine-induced MAPK activity in the islets of Langerhans mainly originates from beta cells because MAPKs are strongly activated in rat insulinoma cells (RIN cells) in response to cytokines [8] . Further cytokine-induced MAPK activation is higher in both transformed and primary sorted beta cells than in alpha cells [40, 41] .
In conclusion, TNFa and IFNg were found to synergise with IL-1b for MAP/SAPK activation. We hypothesise that the synergistic effect of IL-1b, TNFa and IFNg on pancreatic beta-cell NO synthesis, functional inhibition and apoptosis is related to cross-talk between cytokine signalling cascades involving MAPK. 
